Peter Kies - 04 Mar 2026 Form 4 Insider Report for INOVIO PHARMACEUTICALS, INC. (INO)

Role
CFO
Signature
/s/ Peter Kies
Issuer symbol
INO
Transactions as of
04 Mar 2026
Net transactions value
$0
Form type
4
Filing time
05 Mar 2026, 16:54:10 UTC
Previous filing
27 Feb 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
KIES PETER CFO C/O INOVIO PHARMACEUTICALS, INC., 6769 MESA RIDGE ROAD, SAN DIEGO /s/ Peter Kies 05 Mar 2026 0001259780

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INO Common Stock Option Award +31,240 $0.000000* 31,240 04 Mar 2026 Common Stock 31,240 $1.73 Direct F1
transaction INO Restricted Stock Unit Award +25,520 $0.000000* 25,520 04 Mar 2026 Common Stock 25,520 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The vesting schedule for the 31,240 options granted on March 4, 2026 was as follows: 10,414 shares will vest on February 26, 2027; 10,413 shares will vest on February 26, 2028; 10,413 shares will vest on February 26, 2029.
F2 Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 25,520 restricted stock units granted on March 4, 2026 was as follows: 8,507 shares will vest on February 26, 2027; 8,507 shares will vest on February 26, 2028; and 8,506 shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.